Jorge Parra-Ruiz
- Infectious Diseases top 5%
- Antimicrobial Resistance in Staphylococcus 11
- HIV/AIDS drug development and treatment 4
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 6
- Clinical Biochemistry top 5%
- Bacterial Identification and Susceptibility Testing 5
- Virology top 10%
- Microbiology top 10%
-
- Antibiotics Pharmacokinetics and Efficacy 7
-
- Orthopedic Infections and Treatments 6
-
- Pneumonia and Respiratory Infections 6
- Infective Endocarditis Diagnosis and Management 5
- Co-authors
- Céline VidaillacMichael J. RybakJosé Hernández‐QueroWarren E. RoseDiego ParraNorberto Ortego‐CentenoMiguel Ángel Arrabal‐PoloMaría Sierra Girón‐Prieto
- Journals
- PLoS ONE (1 paper)Journal of Clinical Microbiology (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- SpainUnited StatesChile
In The Last Decade
Jorge Parra-Ruiz
47 papers receiving 698 citations
Peers
Comparison fields: 5 of 95
- Infectious Diseases 334
- Molecular Medicine 71
- Clinical Biochemistry 80
- Virology 39
- Microbiology 50
Countries citing papers authored by Jorge Parra-Ruiz
This map shows the geographic impact of Jorge Parra-Ruiz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Parra-Ruiz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Parra-Ruiz more than expected).
Fields of papers citing papers by Jorge Parra-Ruiz
This network shows the impact of papers produced by Jorge Parra-Ruiz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Parra-Ruiz. The network helps show where Jorge Parra-Ruiz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jorge Parra-Ruiz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 14 | |
| 2 | 2022 | 5 | |
| 3 | 2018 | 21 | |
| 4 | 2016 | 4 | |
| 5 | 2015 | 8 | |
| 6 | 2015 | 6 | |
| 7 | 2014 | 26 | |
| 8 | 2013 | 82 | |
| 9 | 2013 | 41 | |
| 10 | Parámetros farmacodinámicos y farmacocinéticos de las fluoroquinolonas respiratorias. Guía para la selección de la fluoroquinolona más apropiada | 2012 | 2 |
| 11 | [Pharmacodynamic and pharmacokinetic evaluation of respiratory fluoroquinolones. Guideline to selection of the most appropriate fluoroquinolone]. | 2012 | 3 |
| 12 | 2012 | 56 | |
| 13 | 2012 | 2 | |
| 14 | 2011 | 21 | |
| 15 | 2007 | 11 | |
| 16 | Perspectivas terapéuticas actuales de la sepsis | 2004 | 1 |
| 17 | 2004 | 1 | |
| 18 | 2003 | 7 | |
| 19 | 2001 | 6 | |
| 20 | 2000 | 7 |
About Jorge Parra-Ruiz
Jorge Parra-Ruiz is a scholar working on Infectious Diseases, Molecular Medicine and Applied Microbiology and Biotechnology, having authored 51 papers that have together received 722 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (11 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Orthopedic Infections and Treatments (6 papers), Pneumonia and Respiratory Infections (6 papers), Antibiotic Resistance in Bacteria (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Infective Endocarditis Diagnosis and Management (5 papers) and HIV/AIDS drug development and treatment (4 papers). The work is most often cited by research in Infectious Diseases (334 citations), Molecular Medicine (71 citations) and Clinical Biochemistry (80 citations). Jorge Parra-Ruiz has collaborated with scholars based in Spain, United States and Chile. Frequent co-authors include Céline Vidaillac, Michael J. Rybak, José Hernández‐Quero, Warren E. Rose, Diego Parra, Norberto Ortego‐Centeno, Miguel Ángel Arrabal‐Polo, María Sierra Girón‐Prieto, Juan Garrido-Gómez and Shuvo Roy. Their work appears in journals such as PLoS ONE, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.